# ENDOLOGIX INC /DE/

ENDOLOGIX INC /DE/ is a company headquartered in Irvine, CA, United States.

## Company overview

- **Legal name:** ENDOLOGIX INC /DE/
- **Former names in filing history:** RADIANCE MEDICAL SYSTEMS INC /DE/ (1999-04-28 to 2002-05-14); CARDIOVASCULAR DYNAMICS INC (1996-08-14 to 1999-01-07)
- **Classification:** Company
- **Industry (SIC):** 3841 — Surgical & Medical Instruments & Apparatus
- **Headquarters:** Irvine, CA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001013606

## About

ENDOLOGIX INC /DE/ is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001013606, and its reported industry is Surgical & Medical Instruments & Apparatus. In 10-K filed on 2020-03-11, it reported annual revenue of USD 143,370,000; net income of USD -64,757,000; total assets of USD 307,164,000 for the fiscal period ended 2019-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2019 (period ended 2019-12-31)

- **Revenue:** $143.4M (USD 143,370,000)
- **Net income:** -$64.8M (USD -64,757,000)
- **Total assets:** $307.2M (USD 307,164,000)
- **Cash and equivalents:** $41.6M (USD 41,560,000)
- **Operating cash flow:** -$29.6M (USD -29,570,000)

### FY2018 (period ended 2018-12-31)

- **Revenue:** $156.5M (USD 156,473,000)
- **Net income:** -$79.7M (USD -79,714,000)
- **Total assets:** $293.1M (USD 293,070,000)
- **Cash and equivalents:** $23.5M (USD 23,531,000)
- **Operating cash flow:** -$38.6M (USD -38,613,000)

### FY2017 (period ended 2017-12-31)

- **Net income:** -$66.4M (USD -66,400,000)
- **Total assets:** $365.0M (USD 365,047,000)
- **Cash and equivalents:** $58.0M (USD 57,991,000)
- **Operating cash flow:** -$38.5M (USD -38,525,000)
- **Later filings:** Operating cash flow: shown as originally filed; later filings report different values for the same periods.

### FY2016 (period ended 2016-12-31)

- **Net income:** -$154.7M (USD -154,677,000)
- **Total assets:** $359.7M (USD 359,684,000)
- **Cash and equivalents:** $26.1M (USD 26,120,000)
- **Operating cash flow:** -$74.8M (USD -74,808,000)
- **Later filings:** Cash and equivalents, Operating cash flow: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form 8-K — filed 2020-10-01 — period 2020-10-01 — 8-K
- Form 8-K — filed 2020-09-22 — period 2020-09-16 — 8-K
- Form 10-Q — filed 2020-08-07 — period 2020-06-30 — 10-Q
- Form 8-K — filed 2020-07-09 — period 2020-07-05 — 8-K
- Form 8-K — filed 2020-07-06 — period 2020-07-05 — 8-K
- Form 8-K — filed 2020-07-01 — period 2020-06-30 — 8-K
- Form 8-K — filed 2020-06-24 — period 2020-06-19 — 8-K
- Form 8-K — filed 2020-06-19 — period 2020-06-19 — 8-K CFO DEPARTURE/APPOINTMENT OF OFFICERS
- Form 8-K — filed 2020-06-15 — period 2020-06-14 — 8-K
- Form 8-K — filed 2020-06-11 — period 2020-06-11 — 8-K 2020 ANNUAL MEETING VOTING RESULTS
- Form 8-K — filed 2020-05-28 — period 2020-05-26 — FORM 8-K
- Form 10-Q — filed 2020-05-27 — period 2020-03-31 — 10-Q Q1 2020

---

Updated: 2026-10-23T20:12:17Z

Canonical page: https://altss.com/profile/endologix-inc-de

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology